Bone Cancer in Dogs (Osteosarcoma)
- Occurrence: very rare
- Location of disease: General/Whole body
When to visit the vet?
Non-urgent see a veterinarian within 2–3 days
If the condition worsens / symptoms persist, consult a veterinarian.
Das Wichtigste auf einen Blick
Osteosarcoma is the most common type of primary bone cancer in dogs and mainly affects the long bones, especially the front and hind legs. This aggressive disease destroys bone tissue, leading to pain and weakening of the bone. The exact causes are unclear, but genetic factors play a role, particularly in large breeds such as Great Danes and Rottweilers. Environmental factors and previous bone injuries could also increase the risk. Symptoms include pain, lameness, and swelling of the bones. Diagnosis is made through clinical examination, X-rays, and biopsies. Treatments often include amputation of the affected limb as well as chemotherapy to slow the progression of the disease. Radiation therapy can be used in certain cases for pain relief. The prognosis is guarded, as the cancer metastasizes early, but treatment can extend survival time. Prevention is difficult, but a healthy diet and regular vet visits can help minimize the risk. Research aims to identify genetic risk factors and develop new treatment methods, including immunotherapy and nutritional studies. These efforts are intended to improve the quality of life for dogs with osteosarcoma.
Ursachen
Osteosarcoma is the most common form of primary bone cancer in dogs, accounting for approximately 85% of all bone tumors. It is a highly malignant disease that typically affects the long bones, especially the front legs (humerus and radius) and the hind legs (femur and tibia). The tumor tends to grow rapidly, destroying normal bone tissue and leading to pain and weakening of the bone.
The exact causes of osteosarcoma development are not fully understood; however, genetic factors play a significant role. Large and giant dog breeds such as Great Danes, Irish Wolfhounds, Saint Bernards, and Rottweilers have an increased risk. Genetic predisposition and growth rate can also influence the development of the disease.
Another possible risk factor is exposure to certain environmental factors, such as chemicals and radiation, although further research is needed to establish a clear connection. Previous bone injuries or surgeries can also be considered risk factors, as they stimulate cell division in the bone and could therefore increase the likelihood of malignant transformation.
Symptoms
Symptoms of osteosarcoma can vary depending on the location of the tumor, but lameness and swelling are often the first signs. The lameness may occur suddenly and is often mistakenly viewed as the result of an injury. The affected limb can be painful and swollen, which is caused by tumor growth and subsequent inflammation.
Further symptoms include weight loss, loss of appetite, and lethargy. In advanced stages, the tumor can metastasize, meaning the cancer spreads to other parts of the body, usually the lungs. This can lead to respiratory distress and a deterioration of the general state of health.
In some cases, a pathological fracture can occur, where the weakened bone breaks even under minimal pressure. This is a serious symptom and requires immediate veterinary care.
Diagnose
The diagnosis of osteosarcoma typically begins with a thorough clinical examination and a detailed medical history to assess the dog’s symptoms and health history. An important diagnostic step is the X-ray examination of the affected limb, which often shows typical changes in the bone, such as a mixture of bone density and bone loss.
To confirm the diagnosis, fine-needle aspiration or a biopsy of the tumor can be performed. The collected cells or tissue samples are examined microscopically to confirm the presence of cancer cells. A biopsy is usually required to make a definitive diagnosis, as other conditions such as infections or other tumor types can produce similar X-ray images.
Additionally, chest X-rays or computed tomography (CT) may be performed to determine the presence of metastasis in the lungs or other organs. Early detection of metastasis is crucial for planning therapy and assessing the prognosis.
Therapie
Treatment of osteosarcoma in dogs typically involves a combination of surgical procedures and chemotherapy. Amputation of the affected limb is often the first choice, as it removes the primary tumor and relieves pain. Although amputation may seem like a drastic measure, most dogs adapt remarkably well to life on three legs.
After surgery, chemotherapy is often recommended to reduce the risk of metastases and prolong survival time. The most commonly used medications are carboplatin, cisplatin, and doxorubicin. These treatments aim to destroy remaining cancer cells and slow the progression of the disease.
In some cases, particularly when amputation is not an option, radiation therapy can be used for pain relief. This form of therapy can help shrink the tumor and improve the quality of life of the affected dog.
Prognose und Nachsorge
The prognosis for dogs with osteosarcoma is generally guarded to poor, as it is an aggressive cancer that tends to metastasize early. Without treatment, most dogs survive only a few months after diagnosis. With a combination of amputation and chemotherapy, however, median survival time can be extended to 10 to 12 months, with some dogs living even longer.
The prognosis is influenced by several factors, including the location of the tumor, the presence of metastases at the time of diagnosis, and the dog’s overall health. Dogs that have no visible metastases at the time of diagnosis tend to have a better prognosis.
Early detection and intervention can significantly improve the quality of life and prolong survival time, with regular veterinary visits and follow-up examinations being crucial.
Prävention
Since the exact causes of osteosarcoma are not fully understood, there are no specific prevention measures. Nevertheless, some general health measures can help minimize the risk.
A balanced diet and regular exercise are important to promote the general well-being and health of the dog. In large breeds, an adapted diet can help regulate growth and minimize stress on the bones.
Regular veterinary examinations are crucial for detecting and treating health problems early. For dogs with a genetic predisposition for osteosarcoma, owners should be particularly vigilant and have unusual symptoms clarified immediately.
Although complete prevention of osteosarcoma is not possible, these measures can help promote overall health and increase the chances of early diagnosis.
Ausblick auf aktuelle Forschung
Research on osteosarcoma in dogs has made significant progress in recent years. One focus is on genetic analyses to identify markers that increase the risk of developing osteosarcoma. These studies are important for better understanding the predisposition of certain dog breeds to this type of cancer. Breeds such as the German Shepherd, the Rottweiler, and the Irish Wolfhound have a higher incidence, suggesting genetic factors. By identifying specific genes associated with the risk of osteosarcoma, scientists hope to develop new preventive strategies and therapeutic approaches.
Another area of research focuses on the development of new treatment methods. Traditionally, osteosarcoma in dogs is treated with a combination of surgical tumor removal, chemotherapy, and occasionally radiation therapy. The challenge is to make these treatments more effective and less stressful for the dogs. Researchers are investigating new chemotherapies and their combinations to improve the survival rate and increase the quality of life for affected dogs.
Intensive research is also being conducted in the field of immunotherapy. This treatment strategy aims to use the dog’s immune system to attack and destroy the cancer cells. Initial studies with immunotherapeutic approaches, such as the use of cancer vaccines or adoptive T-cell therapy, show promising results. However, these therapies are still in the early stages of clinical testing, and further research is required to confirm their efficacy and safety.
The role of nutrition and lifestyle in the prevention and treatment of osteosarcoma is also increasingly being investigated. Some studies suggest that certain diets or dietary supplements could reduce the risk of cancer or improve the response rate to treatment. However, these findings are still preliminary, and further investigation is needed to make concrete recommendations.
In summary, research on osteosarcoma in dogs is progressing on several levels, with the goal of gaining a better understanding of the disease and developing new, more effective treatment approaches. Collaboration between scientists, veterinarians, and dog owners is crucial to achieving these goals and improving the quality of life for dogs with osteosarcoma.
Frequently Asked Questions (FAQs)
1. What is osteosarcoma in dogs?
2. What symptoms do dogs with osteosarcoma show?
3. How is osteosarcoma diagnosed in dogs?
4. What treatment options are available for dogs with osteosarcoma?
5. What are the prognoses for dogs with osteosarcoma?
6. Can osteosarcoma be prevented in dogs?
7. Are certain dog breeds more susceptible to osteosarcoma?
8. What new research is there for the treatment of osteosarcoma?
9. How important is nutrition for a dog with osteosarcoma?
10. Are there alternative therapies that can help with osteosarcoma?
Literatur
- Polton, G., Borrego, J. F., Clemente-Vicario, F., Clifford, C. A., Jagielski, D., Kessler, M., Kobayashi, T., Lanore, D., Queiroga, F. L., Rodrigues, L., Rowe, A. T., Vajdovich, P., & Bergman, P. J. (2025). Osteosarcoma of the appendicular skeleton in dogs: Consensus and guidelines. Frontiers in Veterinary Science, 12, 1633593. https://doi.org/10.3389/fvets.2025.1633593
- Simpson, S., Rizvanov, A. A., Jeyapalan, J. N., de Brot, S., & Rutland, C. S. (2022). Canine osteosarcoma in comparative oncology: Molecular mechanisms through to treatment discovery. Frontiers in Veterinary Science, 9, 965391. https://doi.org/10.3389/fvets.2022.965391
- Szewczyk, M., Lechowski, R., & Zabielska, K. (2015). What do we know about canine osteosarcoma treatment? Veterinary Research Communications, 39(1), 61–67. https://doi.org/10.1007/s11259-014-9623-0
- Selmic, L. E., Burton, J. H., Thamm, D. H., Withrow, S. J., & Lana, S. E. (2014). Comparison of carboplatin and doxorubicin-based chemotherapy protocols in 470 dogs after amputation for treatment of appendicular osteosarcoma. Journal of Veterinary Internal Medicine, 28(2), 554–563. https://doi.org/10.1111/jvim.12313
- Skorupski, K. A., Uhl, J. M., Szivek, A., Frazier, D. A., Rebhun, R. B., & Rodriguez, C. O. (2016). Carboplatin versus alternating carboplatin and doxorubicin for the adjuvant treatment of canine appendicular osteosarcoma: A randomized, phase III trial. Veterinary and Comparative Oncology, 14(1), 81–87. https://doi.org/10.1111/vco.12069
- Frimberger, A. E., Chan, C. M., & Moore, A. S. (2016). Canine osteosarcoma treated by post-amputation sequential accelerated doxorubicin and carboplatin chemotherapy: 38 cases. Journal of the American Animal Hospital Association, 52(3), 149–156. https://doi.org/10.5326/JAAHA-MS-6315